Yecla, Arman D.

HRN: 22-35-65  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/26/2022
CEFTRIAXONE 1G (VIAL)
12/26/2022
01/02/2023
IV
1g
Q12
Fracture
Waiting Final Action 
12/26/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
12/26/2022
01/02/2023
IV
600mg
Q6h
Fracture
Waiting Final Action 
01/04/2023
CEFTRIAXONE 1G (VIAL)
01/04/2023
01/10/2023
IV
1gm
Q12
Fracture
Waiting Final Action 
01/04/2023
CLINDAMYCIN 150MG/ML, 4ML (AMP)
01/04/2023
01/10/2023
IV
600mg
Q6
Fracture
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: